CCN2 and hepatocellular carcinoma: Previous studies have shown that various microRNA targeting CTGF enhanced the expression of E-cadherin in diverse cancers including colorectal cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma [47–49].